ArticleBreast cancer research and treatment2014

Abrogating phosphorylation of eIF4B is required for EGFR and mTOR inhibitor synergy in triple-negative breast cancer.

Julie M Madden et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.